Literature DB >> 22895626

[Technical and methodical developments of radiation oncology from a physician's point of view].

N Willich1.   

Abstract

Technical and methodical developments have changed radiation oncology substantially over the last 40 years. Modern imaging methods, e.g., computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound (US), have not only improved the detection of tumors but have also become tools for computed treatment planning. Megavoltage irradiation with accelerators using photons and electrons with large and small fields, intensity modulation (IMRT), image-guided radiotherapy (IGRT), stereotactic irradiation and radiosurgery, intraoperative radiotherapy (IORT), and modern remote controlled afterloading brachytherapy have made high precision radiotherapy increasingly possible. Hadron therapy has potential for further developments. Radiation oncology today is an interdisciplinary modality and increasingly considers interactions with new drugs and differentiated surgical methods. There is a strong need for comprehensive evaluation of the new methods and also for translational research in biology of tumors and normal tissue biology as well as in medical physics and techniques.

Entities:  

Mesh:

Year:  2012        PMID: 22895626     DOI: 10.1007/s00066-012-0190-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  41 in total

1.  Intensity-modulated radiotherapy: first results with this new technology on neoplasms of the head and neck.

Authors:  R B Kuppersmith; S C Greco; B S Teh; D T Donovan; W Grant; J K Chiu; R B Cain; E B Butler
Journal:  Ear Nose Throat J       Date:  1999-04       Impact factor: 1.697

Review 2.  An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee.

Authors:  Aaron M Allen; Todd Pawlicki; Lei Dong; Eugene Fourkal; Mark Buyyounouski; Keith Cengel; John Plastaras; Mary K Bucci; Torunn I Yock; Luisa Bonilla; Robert Price; Eleanor E Harris; Andre A Konski
Journal:  Radiother Oncol       Date:  2012-03-09       Impact factor: 6.280

3.  Clinical research in stereotactic radiosurgery: lessons learned from over 10,000 cases.

Authors:  Douglas Kondziolka; John C Flickinger; L Dade Lunsford
Journal:  Neurol Res       Date:  2011-10       Impact factor: 2.448

Review 4.  The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.

Authors:  Minesh P Mehta; May N Tsao; Timothy J Whelan; David E Morris; James A Hayman; John C Flickinger; Michael Mills; C Leland Rogers; Luis Souhami
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

Review 5.  Modern treatment of Hodgkin lymphoma.

Authors:  Nancy L Bartlett
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

6.  Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy.

Authors:  L L Gunderson; H Sosin
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

7.  Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques.

Authors:  K S Chao; N Majhail; C J Huang; J R Simpson; C A Perez; B Haughey; G Spector
Journal:  Radiother Oncol       Date:  2001-12       Impact factor: 6.280

8.  Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience.

Authors:  Suzanne L Wolden; William C Chen; David G Pfister; Dennis H Kraus; Sean L Berry; Michael J Zelefsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-02       Impact factor: 7.038

9.  Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.

Authors:  M J Zelefsky; Z Fuks; L Happersett; H J Lee; C C Ling; C M Burman; M Hunt; T Wolfe; E S Venkatraman; A Jackson; M Skwarchuk; S A Leibel
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

10.  (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.

Authors:  Sonal Sura; Carlo Greco; Daphna Gelblum; Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-01       Impact factor: 7.038

View more
  3 in total

1.  Interstitial brachytherapy for eyelid carcinoma. Outcome analysis in 60 patients.

Authors:  M Krengli; L Masini; A M Comoli; E Negri; L Deantonio; A Filomeno; G Gambaro
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

2.  Clinical and technical characteristics of intraoperative radiotherapy. Analysis of the ISIORT-Europe database.

Authors:  M Krengli; F A Calvo; F Sedlmayer; C V Sole; G Fastner; M Alessandro; S Maluta; R Corvò; E Sperk; M Litoborski; C Pisani; C Fillini; F Fusconi; M F Osti; L Tomio; H Marsiglia; A Ciabattoni; W Polkowski; A Di Grazia; A Gava; A Kuten; C Iotti; C Gonzalez; M Sallabanda; J-B Dubois; G Catalano; V Valentini
Journal:  Strahlenther Onkol       Date:  2013-07-12       Impact factor: 3.621

3.  Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer.

Authors:  Thomas Kuhnt; Andreas Stang; Andreas Wienke; Dirk Vordermark; Ramona Schweyen; Jeremias Hey
Journal:  Radiat Oncol       Date:  2016-07-30       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.